|
1
|
Louis DN: Molecular pathology of malignant
gliomas. Annu Rev Pathol. 1:97–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO Classification of Tumours of the Central Nervous System. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aitken A: 14-3-3 proteins: A historic
overview. Semin Cancer Biol. 16:162–172. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tzivion G, Gupta VS, Kaplun L and Balan V:
14-3-3 proteins as potential oncogenes. Semin Cancer Biol.
16:203–213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hermeking H: The 14-3-3 cancer connection.
Nat Rev Cancer. 3:931–943. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qi W, Liu X, Qiao D and Martinez JD:
Isoform-specific expression of 14-3-3 proteins in human lung cancer
tissues. Int J Cancer. 113:359–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Zhao J, Du Y, Park HR, Sun SY,
Bernal-Mizrachi L, Aitken A, Khuri FR and Fu H: Down-regulation of
14-3-3zeta suppresses anchorage-independent growth of lung cancer
cells through anoikis activation. Proc Natl Acad Sci USA. 105:pp.
162–167. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li DJ, Deng G, Xiao ZQ, Yao HX, Li C, Peng
F, Li MY, Zhang PF, Chen YH and Chen ZC: Identificating 14-3-3
sigma as a lymph node metastasis-related protein in human lung
squamous carcinoma. Cancer Lett. 279:65–73. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yi B, Tan SX, Tang CE, Huang WG, Cheng AL,
Li C, Zhang PF, Li MY, Li JL, Yi H, et al: Inactivation of 14-3-3
sigma by promoter methylation correlates with metastasis in
nasopharyngeal carcinoma. J Cell Biochem. 106:858–866. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akahira J, Sugihashi Y, Suzuki T, Ito K,
Niikura H, Moriya T, Nitta M, Okamura H, Inoue S, Sasano H, et al:
Decreased expression of 14-3-3 sigma is associated with advanced
disease in human epithelial ovarian cancer: Its correlation with
aberrant DNA methylation. Clin Cancer Res. 10:2687–2693. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang X, Cao W, Lin H, Zhang W, Lin W, Cao
L, Zhen H, Huo J and Zhang X: Isoform-specific expression of 14-3-3
proteins in human astrocytoma. J Neurol Sci. 276:54–59. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sugiyama A, Miyagi Y, Komiya Y, Kurabe N,
Kitanaka C, Kato N, Nagashima Y, Kuchino Y and Tashiro F: Forced
expression of antisense 14-3-3beta RNA suppresses tumor cell growth
in vitro and in vivo. Carcinogenesis. 24:1549–1559.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takihara Y, Matsuda Y and Hara J: Role of
the beta isoform of 14-3-3 proteins in cellular proliferation and
oncogenic transformation. Carcinogenesis. 21:2073–2077. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Musholt TJ, Brehm C, Hanack J, von
Wasielewski R and Musholt PB: Identification of differentially
expressed genes in papillary thyroid carcinomas with and without
rearrangements of the tyrosine kinase receptors RET and/or NTRK1. J
Surg Res. 131:15–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng Y, Li Y, Chen RS, He X, Yang L and Li
W: Overexpression of xCT induces up-regulation of 14-3-3beta in
Kaposi's sarcoma. Biosci Rep. 30:277–283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baxter HC, Fraser JR, Liu WG, Forster JL,
Clokie S, Steinacker P, Otto M, Bahn E, Wiltfang J and Aitken A:
Specific 14-3-3 isoform detection and immunolocalization in prion
diseases. Biochem Soc Trans. 30:387–391. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Boston PF, Jackson P, Kynoch PA and
Thompson RJ: Purification, properties, and immunohistochemical
localisation of human brain 14-3-3 protein. J Neurochem.
38:1466–1474. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yan Y, Xu Y, Gao YY, Zong ZH, Zhang Q, Li
C and Wang HQ: Implication of 14-3-3ε and 14-3-3θ/τ in proteasome
inhibition-induced apoptosis of glioma cells. Cancer Sci.
104:55–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao W, Yang X, Zhou J, Teng Z, Cao L,
Zhang X and Fei Z: Targeting 14-3-3 protein, difopein induces
apoptosis of human glioma cells and suppresses tumor growth in
mice. Apoptosis. 15:230–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park SG, Jung S, Ryu HH, Jung TY, Moon KS,
Kim IY, Jeong YI, Pei J, Park SJ and Kang SS: Role of 14-3-3-beta
in the migration and invasion in human malignant glioma cell line
U87MG. Neurol Res. 34:893–900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Timerman D and Yeung CM: Identity
confusion of glioma cell lines. Gene. 536:221–222. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis. Flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baldin V: 14-3-3 proteins and growth
control. Prog Cell Cycle Res. 4:49–60. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tzivion G, Shen YH and Zhu J: 14-3-3
proteins; bringing new definitions to scaffolding. Oncogene.
20:6331–6338. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wilker E and Yaffe MB: 14-3-3 Proteins-a
focus on cancer and human disease. J Mol Cell Cardiol. 37:633–642.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zang D, Li X and Zhang L: 14-3-3zeta
Overexpression and abnormal β-catenin expression are associated
with poor differentiation and progression in stage I non-small cell
lung cancer. Clin Exp Med. 10:221–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo J, Feng J, Lu J, Wang Y, Tang X, Xie F
and Li W: Aberrant methylation profile of 14-3-3 sigma and its
reduced transcription/expression levels in Chinese sporadic female
breast carcinogenesis. Med Oncol. 27:791–797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okita Y, Narita Y, Miyakita Y, Ohno M,
Fukushima S, Kayama T and Shibui S: Pathological findings and
prognostic factors in recurrent glioblastomas. Brain Tumor Pathol.
29:192–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fu H, Subramanian RR and Masters SC:
14-3-3 proteins: Structure, function, and regulation. Annu Rev
Pharmacol Toxicol. 40:617–647. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mhawech P: 14-3-3 proteins-an update. Cell
Res. 15:228–236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gong F, Wang G, Ye J, Li T, Bai H and Wang
W: 14-3-3β regulates the proliferation of glioma cells through the
GSK3β/β-catenin signaling pathway. Oncol Rep. 30:2976–2982. 2013.
View Article : Google Scholar : PubMed/NCBI
|
